🍂 Enjoy the Fall Season! 🍂
MindTheDesk

A new ADHD drug just got FDA approval. Here's what makes it different.

General Idaho Archived • July 27, 2026 • 2 views
A new ADHD drug just got FDA approval. Here's what makes it different.
  The Food and Drug Administration (FDA) just approved Simtriyo (centanafadine), a new norepinephrine, dopamine, serotonin reuptake inhibitor (NDSRI) and central nervous system (CNS) stimulant. The medication treats ADHD in adults, teens, and children ages 6 and up weighing at least 44 pounds. Most stimulant and non-stimulant ADHD medications raise the levels of two different
Source: https://localnews8.com/feed/ - Read Original
"Monetize your website or boost your business with Code-Oryx. Join the network today!"

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"House Plans for Structures New and Old"
"Free Quote Today"